Adaptimmune Therapeutics PLC (ADAPY) vs Quantum Biopharma Ltd. (QNTM)
- Adaptimmune Therapeutics PLC ADAPY 0.03 0.00%
- Quantum Biopharma Ltd. QNTM 1.61 −9.55%
Adaptimmune Therapeutics PLC and Quantum Biopharma Ltd. are both Biotechnology companies. Adaptimmune Therapeutics PLC and Quantum Biopharma Ltd. are of similar size ($14.6M and $14.4M). Quantum Biopharma Ltd. has the higher net margin (0.00% vs −262.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Adaptimmune Therapeutics PLC leads on 7 and Quantum Biopharma Ltd. on 7.
Valuation
Profitability
| Metric | ADAPY | QNTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.81% | 0.00% | 67.24% |
| Operating margin | (427.75%) | 0.00% | 0.00% |
| Net margin | (262.46%) | 0.00% | 0.00% |
| Free cash flow margin | (294.49%) | 0.00% | 0.00% |
| Return on equity | (1,349.52%) | (618.06%) | (50.28%) |
| Return on assets | 0.00% | (169.48%) | (45.89%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack